Fujifilm Diosynth Biotechnologies
pAVEway™: A Novel Platform for the Advanced Production of Protein Therapeutics
- Company Details
- Products & Services
- White Papers
- Press Releases
- Regional Offices
- Contact Company
The pAVEway™ platform developed by Fujifilm Diosynth Biotechnologies is based on a set of unique protein expression plasmids.
The pAVEway™ platform developed by Fujifilm Diosynth Biotechnologies is...
Fujifilm Diosynth Biotechnologies has over 180 process development scientists...
A pre-cGMP pilot-scale fermenter ensures that processes can be rapidly...
A full range of manufacturing support services is offered, including...
On-site cGMP cell banking facilities for the production of master and working...